Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progressive Idiopathic Pulmonary Fibrosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07466420
What this trial is testing

Study on the Efficacy of Quercetin Intake in Patients With Fibrotic Interstitial Lung Diseases.

Who this might be right for
Fibrotic Interstitial Lungs DiseasesIdiopathic Pulmonary Fibrosis (IPF)Progressive Pulmonary Fibrosis
Katerina M. Antoniou 100
Large-scale testing (Phase 3)Enrolling By InvitationNCT04905693
What this trial is testing

Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease

Who this might be right for
Idiopathic Pulmonary FibrosisInterstitial Lung DiseaseProgressive Pulmonary Fibrosis
United Therapeutics 1,850
Not applicableActive Not RecruitingNCT07577115
What this trial is testing

Occupational and Environmental Exposures Analysis in Interstitial Lung Diseases.

Who this might be right for
Interstitial Lung Disease Due to Systemic Disease (Disorder)Interstitial Lung Disease Due to Systemic Disease (Telomere Biology Disorder)Exposure Occupational+10 more
Istituto Clinico Humanitas 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT06422884
What this trial is testing

Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Fibrosing Interstitial Lung Disease
Endeavor Biomedicines, Inc. 213
Testing effectiveness (Phase 2)Ended earlyNCT01266135
What this trial is testing

Safety and Efficacy of QAX576 in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 40
Not applicableUnknownNCT05445817
What this trial is testing

Pulmonary Care and Research Collaborative Patient Registry

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 150
Not applicableNo Longer AvailableNCT04739150
What this trial is testing

An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options

Who this might be right for
Lung Diseases, Interstitial
Boehringer Ingelheim
Testing effectiveness (Phase 2)Active Not RecruitingNCT05828953
What this trial is testing

Anlotinib Capsules in the Treatment for IPF/PF-ILDs

Who this might be right for
Interstitial Lung Diseases
First Affiliated Hospital of Wenzhou Medical University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06238622
What this trial is testing

A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 1,666
Testing effectiveness (Phase 2)Looking for participantsNCT06951217
What this trial is testing

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

Who this might be right for
Progressive Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
Avalyn Pharma Inc. 340
Testing effectiveness (Phase 2)Study completedNCT04308681
What this trial is testing

A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 403
Not applicableUnknownNCT05455437
What this trial is testing

Monitoring and Evaluation Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Diseases
Pulmonary Care and Research Collaborative Limited 200
Testing effectiveness (Phase 2)Looking for participantsNCT07572383
What this trial is testing

Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibrosis

Who this might be right for
Interstitial Lung DiseasePulmonary Fibrosis
Peter Caravan 15
Not applicableLooking for participantsNCT06162884
What this trial is testing

Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
University of California, Los Angeles 200
Testing effectiveness (Phase 2)Ended earlyNCT06360094
What this trial is testing

Test Whether BI 1839100 Improves Cough in People With Idiopathic Pulmonary Fibrosis or Progressive Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Boehringer Ingelheim 85
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441408
What this trial is testing

Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis

Who this might be right for
Pulmonary Fibrosis
Bristol-Myers Squibb 2,380
Testing effectiveness (Phase 2)Study completedNCT02594839
What this trial is testing

Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Who this might be right for
Idiopathic Interstitial PneumoniaInterstitial Lung DiseaseIdiopathic Pulmonary Fibrosis
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05241275
What this trial is testing

Xenon MRI and Progressive ILD

Who this might be right for
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Duke University 60
Not applicableNot Yet RecruitingNCT07673237
What this trial is testing

Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring

Who this might be right for
Fibrotic Interstitial Lung DiseaseIPF and PPFLung Fibrosis Interstitial
University of California, San Francisco 200
Early research (Phase 1)Ended earlyNCT05644600
What this trial is testing

Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.

Who this might be right for
Healthy Subjects
AstraZeneca 18
Next Page